Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 20 de 56
Filtrar
1.
J Ethnopharmacol ; 275: 114139, 2021 Jul 15.
Artículo en Inglés | MEDLINE | ID: mdl-33894286

RESUMEN

ETHNOPHARMACOLOGICAL RELEVANCE: Diabetes mellitus (DM), as a multiorgan syndrome, is an endocrine and metabolic disorder that is associated with male reproductive system dysfunction and infertility. Safflower (Carthamus tinctorius L.) as an herbal remedy improves DM and infertility-related disorders. The anti-hypercholesterolemic, anti-inflammatory, and antioxidative properties of this herb have been well documented, but its role in testosterone production, male reproductive system and zinc homeostasis has not been fully illustrated. AIM OF THE STUDY: This study aimed to investigate the preventive and therapeutic properties of different doses of safflower seed oil against reproductive damage caused by type II DM by investigating zinc element homeostasis, inflammation and oxidative damage in testis tissue and their relationship with testosterone production and sperm parameters. MATERIALS AND METHODS: Eighty adult male Sprague-Dawley rats were randomly divided into eight groups and treated daily for 12 and 24 weeks in protective and therapeutic studies, respectively. Type II DM was induced by a High Fat Diet (HFD) in normoglycemic rats for three months. At the end of each study, serum level of glucose, testosterone, gonadotropins, TNF-α, insulin, and leptin were measured. Moreover, antioxidant enzymes activity, lipid peroxidation, zinc and testosterone along with the expression of Nrf-2, NF-κB, TNF-α, StAR, P450scc, and 17ßHSD3 genes in the testis were detected. RESULTS: After the intervention, the activity of antioxidant enzymes and the level of testosterone and gonadotropins significantly decreased in the rats with DM in comparison to the others. However, lipid peroxidation and serum level of insulin, leptin and TNF-α increased and the testicular level of zinc significantly changed in the rats with DM compared to the control groups (p < 0.05). The gene expression of NF-κB and TNF-α were also significantly increased and the gene expression of Nrf2, StAR, P450scc and 17ßHSD3 were decreased in the testis of diabetic rats (p < 0.05). The results showed that pretreatment and treatment with safflower seed oil could improve these parameters in diabetic rats compared with untreated diabetic rats (p < 0.05). CONCLUSION: HFD could impair the production of testosterone and sperm, and reduce gonadotropin by increasing the serum level of leptin and inducing insulin resistance, oxidative stress and inflammation. However, safflower oil in a dose-dependent manner could improve testosterone level and sperm parameters by improving the level of leptin, zinc and insulin resistance, and the genes expression involved in testosterone synthesis, inflammation and oxidative stress.


Asunto(s)
Antioxidantes/farmacología , Diabetes Mellitus Experimental/tratamiento farmacológico , Inflamación/genética , Lipogénesis/genética , Estrés Oxidativo/genética , Aceite de Cártamo/farmacología , Espermatogénesis/genética , Animales , Antioxidantes/análisis , Antioxidantes/uso terapéutico , Glucemia/efectos de los fármacos , Peso Corporal/efectos de los fármacos , Diabetes Mellitus Experimental/inducido químicamente , Diabetes Mellitus Experimental/complicaciones , Diabetes Mellitus Tipo 2 , Dieta Alta en Grasa/efectos adversos , Ingestión de Alimentos/efectos de los fármacos , Regulación de la Expresión Génica/efectos de los fármacos , Gonadotropinas/sangre , Inflamación/metabolismo , Insulina/sangre , Leptina/sangre , Peroxidación de Lípido/efectos de los fármacos , Lipogénesis/efectos de los fármacos , Masculino , Estrés Oxidativo/efectos de los fármacos , Ratas Sprague-Dawley , Aceite de Cártamo/química , Aceite de Cártamo/uso terapéutico , Semillas/química , Espermatogénesis/efectos de los fármacos , Espermatozoides/efectos de los fármacos , Esteroides/metabolismo , Testículo/efectos de los fármacos , Testículo/metabolismo , Testículo/patología , Testosterona/metabolismo , Factor de Necrosis Tumoral alfa/metabolismo , Zinc/sangre
2.
World J Surg Oncol ; 16(1): 167, 2018 Aug 13.
Artículo en Inglés | MEDLINE | ID: mdl-30103745

RESUMEN

BACKGROUND: Safflower polysaccharide (SPS) is one of the most important active components of safflower (Carthamus tinctorius L.), which has been confirmed to have the immune-regulatory function and antitumor effect. This study aimed to explore the effects of safflower polysaccharide (SPS) on tongue squamous cell carcinoma (TSCC). METHODS: HN-6 cells were treated with 5 µg/mL cisplatin and various concentrations of SPS (0, 0.02, 0.04, 0.08, 0.16, 0.32, 0.64, and 1.28 mg/mL), and cell proliferation was measured. After treatment with 5 µg/mL cisplatin and 0.64 mg/mL SPS, the induction of apoptosis and the protein and mRNA expression of Bax, Bcl-2, COX-2, and cleaved caspase-3 in HN-6 cells were quantified. In addition, HN-6 cells were implanted into mice to establish an in vivo tumor xenograft model. Animals were randomly assigned to three groups: SPS treatment, cisplatin treatment, and the model group (no treatment). The body weight, tumor volume, and tumor weight were measured, and the expression of the above molecules was determined. RESULTS: SPS treatment (0.02-0.64 mg/mL) for 24-72 h inhibited HN-6 cell proliferation. In addition, 0.64 mg/mL SFP markedly induced apoptosis in HN-6 cells and arrested the cell cycle at the G0/G1 phase. Compared with the control group, the expression of Bcl-2 and COX-2 was markedly reduced by SPS treatment, whereas the expression of Bax and cleaved caspase-3 was increased. Moreover, SPS significantly inhibited the growth of the tumor xenograft, with similar changes in the expression of Bcl-2, COX-2, Bax, and cleaved caspase-3 in the tumor xenograft to the in vitro analysis. CONCLUSIONS: Our results indicated that SPS may inhibit TSCC development through regulation of Bcl-2, COX-2, Bax, and cleaved caspase-3 expression.


Asunto(s)
Carcinoma de Células Escamosas/terapia , Polisacáridos/uso terapéutico , Aceite de Cártamo/uso terapéutico , Neoplasias de la Lengua/terapia , Animales , Apoptosis/efectos de los fármacos , Carcinoma de Células Escamosas/metabolismo , Caspasa 3/biosíntesis , Línea Celular Tumoral , Proliferación Celular/efectos de los fármacos , Ciclooxigenasa 2/biosíntesis , Femenino , Humanos , Ratones , Pronóstico , Proteínas Proto-Oncogénicas c-bcl-2/biosíntesis , Neoplasias de la Lengua/metabolismo , Proteína X Asociada a bcl-2/biosíntesis
3.
Int J Cosmet Sci ; 40(1): 81-86, 2018 Feb.
Artículo en Inglés | MEDLINE | ID: mdl-29094366

RESUMEN

OBJECTIVE: The normal process of skin tissue repair following injury invariably results in visual scarring. It is known that topical treatment with hydrophobic cosmetics rich in silicone and mineral oil content can improve the appearance of scars and striae. Given lifestyle preferences of many cosmetic consumers towards so-called natural treatments, the objective of this controlled randomized study was to investigate the efficacy of a plant body oil rich in oleic and linoleic acids (Bio Skin Oil® ) for improving the appearance of scars and striae. METHODS: A panel of 80 volunteers with non-hypertrophic scars (40) or stretch marks (40) not older than 3 years applied a cosmetic face and body oil for 8 weeks. Compared to an untreated scar/stretch mark region, a blinded investigator as well as volunteer assessments with given observed parameters demonstrated the efficacy of the oil under test. RESULTS: On the Observer Scar Assessment Scale (OSAS), the mean score was reduced on the product-treated area by approximately 5% (P = 0.006). The untreated area remained unchanged. Observed effects by volunteers were more pronounced - Patient Scar Assessment Scale (PSAS) giving a reduction of approximately 20% on the treated area, and on the control untreated area a reduction of approximately 6%. The overall product effect of 14% was shown to be clearly significant (P = 0.001). All statements relating to product traits achieved higher frequencies of agreements than of non-agreements and were therefore assessed positively by the volunteers. Highest frequencies of agreements occurred in statements that the test product provides a long-lasting, soft and supple skin feeling (93%); caring effect (87%); and quick absorbance (84%). Agreement was also found for statements that the product improves the skin appearance (61%) and that scars/striae appear less pronounced (51%). Only 17% of volunteers felt the oil had no benefit to the appearance of their scars/striae. CONCLUSIONS: The oil blend under test is effective in improving the appearance of non-keloid scars and striae. Further work is required to understand the mechanisms of how plant oil fatty acids ameliorate scar and striae appearance.


Asunto(s)
Cicatriz/terapia , Cosméticos , Aceites de Plantas/uso terapéutico , Estrías de Distensión/terapia , Adulto , Femenino , Humanos , Masculino , Persona de Mediana Edad , Variaciones Dependientes del Observador , Aceite de Oliva/administración & dosificación , Aceite de Oliva/uso terapéutico , Aceites de Plantas/administración & dosificación , Aceite de Cártamo/administración & dosificación , Aceite de Cártamo/uso terapéutico , Adulto Joven
4.
Endocr Regul ; 50(4): 183-193, 2016 Oct 01.
Artículo en Inglés | MEDLINE | ID: mdl-27941179

RESUMEN

OBJECTIVES: Elevated total serum free fatty acids (FFAs) concentrations have been suggested, controversially, to enhance insulin resistance and decrease percent remaining ß-cell function. However, concentrations of individual serum FFAs have never been published in terms of their relationship (correlation) to homeostatic model assessment-insulin resistance (HOMA-IR) and percent remaining ß-cell function (HOMA-%ß) in the type 2 diabetics (T2Ds). Alpha-linolenic acid consumption has a negative correlation with the insulin resistance, which in turn is negatively correlated with the remaining ß-cell function. The primary objective was to test the hypothesis that there would be different relationship (correlation) between the blood serum individual free FFA mol % levels and HOMA-IR and/or HOMA-%ß in T2D. The secondary objective was to test the hypothesis that flaxseed oil, previously being shown to be ineffective in the glycemic control in T2Ds, may alter these correlations in a statistically significant manner as well as HOMA-IR and/or HOMA-%ß. METHODS: Patients were recruited via a newspaper advertisement and two physicians have been employed. All the patients came to visit one and three months later for a second visit. At the second visit, the subjects were randomly assigned (double blind) to flaxseed or safflower oil treatment for three months, until the third visit. RESULTS: Different statistically significant correlations or trends towards among some serum individual free FFA mol % levels and HOMA-IR and HOMA-%ß, pre- and post-flaxseed and safflower oil supplementation were found. However, flaxseed oil had no impact on HOMA-IR or HOMA-%ß despite statistically significant alterations in correlations compared to baseline HOMA-IR. CONCLUSIONS: The obtained data indicate that high doses of flaxseed oil have no statistically significant effect on HOMA-IR or HOMA-%ß in T2Ds, probably due to the additive effects of negative and positive correlations.


Asunto(s)
Glucemia/metabolismo , Diabetes Mellitus Tipo 2/tratamiento farmacológico , Ácidos Grasos no Esterificados/sangre , Resistencia a la Insulina , Células Secretoras de Insulina/metabolismo , Insulina/sangre , Aceite de Linaza/uso terapéutico , Ácido alfa-Linolénico/uso terapéutico , Cromatografía Líquida de Alta Presión , Diabetes Mellitus Tipo 2/sangre , Diabetes Mellitus Tipo 2/metabolismo , Suplementos Dietéticos , Método Doble Ciego , Femenino , Humanos , Masculino , Persona de Mediana Edad , Aceite de Cártamo/uso terapéutico
5.
Appl Physiol Nutr Metab ; 41(12): 1271-1277, 2016 Dec.
Artículo en Inglés | MEDLINE | ID: mdl-27863203

RESUMEN

Carthamus tinctorius L. (common name: safflower) is an herb whose extracted oil (safflower oil) has been employed in both alternative and conventional medicine in the treatment of disease. Overnutrition during early postnatal life can increase the lifetime risk of obesity and metabolic syndrome. Here we investigate the effect of safflower oil supplementation given during a critical early developmental stage on the eventual occurrence of metabolic disease in overnourished rats. Groups of overnourished or adequately nourished rats were randomly assigned into 2 additional groups for supplementation with either safflower oil (SF) or vehicle for 7 to 30 days. Murinometric data and weights were examined. Serum was collected for measurement of glucose, cholesterol, high-density lipoprotein cholesterol, and triglycerides. Heart and liver oxidative status were also measured. Overnutrition for 7-30 days induced a significant increase in body weight and in values for abdominal circumference, thoracic circumference, body length, and body mass index. SF supplementation did not attenuate the effect of overnutrition on any of these parameters. In addition, overnutrition increased levels of glucose, triglycerides, and very low-density lipid compared with normal controls, but SF supplementation had no effect on these parameters. Measures of oxidative status in heart or liver were not influenced by overnutrition. However, oxidative measures were altered by SF supplementation in both of these organs. The present study reveals that nutritional manipulation during early development induces detrimental effects on metabolism in the adult that are not ameliorated by supplemental SF.


Asunto(s)
Carthamus tinctorius/química , Ácidos Grasos Omega-6/uso terapéutico , Hígado/metabolismo , Miocardio/metabolismo , Hipernutrición/dietoterapia , Estrés Oxidativo , Aceite de Cártamo/uso terapéutico , Animales , Suplementos Dietéticos/efectos adversos , Ácidos Grasos Omega-6/efectos adversos , Femenino , Hiperglucemia/etiología , Hiperlipidemias/etiología , Lactancia , Masculino , Fenómenos Fisiologicos Nutricionales Maternos , Obesidad/etiología , Obesidad/prevención & control , Hipernutrición/sangre , Hipernutrición/metabolismo , Hipernutrición/fisiopatología , Preparaciones de Plantas/efectos adversos , Preparaciones de Plantas/uso terapéutico , Embarazo , Distribución Aleatoria , Ratas Wistar , Aceite de Cártamo/efectos adversos , Destete , Aumento de Peso
6.
Chin J Integr Med ; 21(3): 229-33, 2015 Mar.
Artículo en Inglés | MEDLINE | ID: mdl-24142260

RESUMEN

OBJECTIVE: To observe the protective effects of safflor Injection (SI) and extract of Ginkgo biloba (EGB) on lung ischemia-reperfusion injury (LIRI) and investigate its mechanism. METHODS: In vivo rabbit model of LIRI was reconstructed. Forty rabbits were randomly and equally divided into four groups: sham-operation group (sham group), ischemia-reperfusion group (model group), ischemia-reperfusion plus SI group (safflor group) and ischemia-reperfusion plus EGB injection group (EGB group). Malondialdehyde (MDA) content, superoxide dismutase (SOD) and xanthine oxidase (XO) activity in serum were measured. The wet/dry weight ratio (W/D) of the lung tissue and activity of myeloperoxidase (MPO) were also tested. Ultrastructure change of the lung tissue was observed by the electron microscope. The expression of intercellular adhesion molecule-1 (ICAM-1) was measured by immunohistochemistry (IHC). RESULTS: In the model group, MDA and XO increased and SOD decreased in serum compared with the sham group (P<0.01). The values of W/D, MPO and ICAM-1 of the model group were higher than those of the sham group (P<0.01), but those of the safflor group and EGB group were significantly lower than those of the model group (P<0.01). The IHC demonstrated that ICAM-1 expression in lung tissue of the model group was significantly higher than those of the safflor group (P<0.01). Compared with safflor group, in the EGB group MDA, XO, MPO decreased, SOD and ICAM-1 expression increased (P<0.05), but the change of W/D was not statistically significant (P>0.05). CONCLUSIONS: SI and EGB may attenuate LIRI through antioxidation, inhibition of neutrophil aggregation and down-regulation of ICAM-1 expression. But EGB had more effect on the antioxidation, while SI did better on regulating ICAM-1 expression.


Asunto(s)
Ginkgo biloba/química , Pulmón/irrigación sanguínea , Extractos Vegetales/uso terapéutico , Sustancias Protectoras/uso terapéutico , Daño por Reperfusión/tratamiento farmacológico , Aceite de Cártamo/uso terapéutico , Animales , Femenino , Inmunohistoquímica , Inyecciones , Molécula 1 de Adhesión Intercelular/metabolismo , Pulmón/patología , Masculino , Malondialdehído/metabolismo , Extractos Vegetales/administración & dosificación , Extractos Vegetales/farmacología , Sustancias Protectoras/administración & dosificación , Sustancias Protectoras/farmacología , Conejos , Daño por Reperfusión/sangre , Aceite de Cártamo/administración & dosificación , Aceite de Cártamo/farmacología , Superóxido Dismutasa/sangre , Xantina Oxidasa/sangre
7.
Intensive Care Med ; 39(10): 1683-94, 2013 Oct.
Artículo en Inglés | MEDLINE | ID: mdl-23812404

RESUMEN

PURPOSE: Parenteral lipid emulsions (LEs) are commonly rich in long-chain triglycerides derived from soybean oil (SO). SO-containing emulsions may promote systemic inflammation and therefore may adversely affect clinical outcomes. We hypothesized that alternative oil-based LEs (SO-sparing strategies) may improve clinical outcomes in critically ill adult patients compared to products containing SO emulsion only. The purpose of this systematic review was to evaluate the effect of parenteral SO-sparing strategies on clinical outcomes in intensive care unit (ICU) patients. METHODS: We searched computerized databases from 1980 to 2013. We included randomized controlled trials (RCTs) conducted in critically ill adult patients that evaluated SO-sparing strategies versus SO-based LEs in the context of parenteral nutrition. RESULTS: A total of 12 RCTs met the inclusion criteria. When the results of these RCTs were statistically aggregated, SO-sparing strategies were associated with clinically important reductions in mortality (risk ratio, RR 0.83; 95 % confidence intervals, CI 0.62, 1.11; P = 0.20), in duration of ventilation (weighted mean difference, WMD -2.57; 95 % CI -5.51, 0.37; P = 0.09), and in ICU length of stay (LOS) (WMD -2.31; 95 % CI -5.28, 0.66; P = 0.13) but none of these differences were statistically significant. SO-sparing strategies had no effect on infectious complications (RR 1.13; 95 % CI 0.87, 1.46; P = 0.35). CONCLUSION: Alternative oil-based LEs may be associated with clinically important reductions in mortality, duration of ventilation, and ICU LOS but lack of statistical precision precludes any clinical recommendations at this time. Further research is warranted to confirm these potential positive treatment effects.


Asunto(s)
Enfermedad Crítica/terapia , Emulsiones Grasas Intravenosas/uso terapéutico , Sistema Inmunológico/efectos de los fármacos , Estrés Oxidativo/efectos de los fármacos , Nutrición Parenteral/métodos , Aceites de Plantas/uso terapéutico , Adulto , Bases de Datos Bibliográficas , Emulsiones/administración & dosificación , Emulsiones/efectos adversos , Emulsiones/uso terapéutico , Emulsiones Grasas Intravenosas/efectos adversos , Emulsiones Grasas Intravenosas/química , Aceites de Pescado/administración & dosificación , Aceites de Pescado/efectos adversos , Aceites de Pescado/uso terapéutico , Humanos , Sistema Inmunológico/fisiología , Inflamación/etiología , Inflamación/prevención & control , Unidades de Cuidados Intensivos , Lecitinas/administración & dosificación , Lecitinas/efectos adversos , Lecitinas/uso terapéutico , Estrés Oxidativo/fisiología , Nutrición Parenteral/efectos adversos , Fosfolípidos/administración & dosificación , Fosfolípidos/efectos adversos , Fosfolípidos/uso terapéutico , Aceites de Plantas/administración & dosificación , Aceites de Plantas/efectos adversos , Ensayos Clínicos Controlados Aleatorios como Asunto , Aceite de Cártamo/administración & dosificación , Aceite de Cártamo/efectos adversos , Aceite de Cártamo/uso terapéutico , Aceite de Soja/administración & dosificación , Aceite de Soja/efectos adversos , Aceite de Soja/uso terapéutico , Resultado del Tratamiento , Triglicéridos/administración & dosificación , Triglicéridos/efectos adversos , Triglicéridos/uso terapéutico
8.
Cardiovasc Res ; 94(3): 460-8, 2012 Jun 01.
Artículo en Inglés | MEDLINE | ID: mdl-22411972

RESUMEN

AIMS: Cardiolipin (CL) is a tetra-acyl phospholipid that provides structural and functional support to several proteins in the inner mitochondrial membrane. The majority of CL in the healthy mammalian heart contains four linoleic acid acyl chains (L(4)CL). A selective loss of L(4)CL is associated with mitochondrial dysfunction and heart failure in humans and animal models. We examined whether supplementing the diet with linoleic acid would preserve cardiac L(4)CL and attenuate mitochondrial dysfunction and contractile failure in rats with hypertensive heart failure. METHODS AND RESULTS: Male spontaneously hypertensive heart failure rats (21 months of age) were administered diets supplemented with high-linoleate safflower oil (HLSO) or lard (10% w/w; 28% kilocalorie fat) or without supplemental fat (control) for 4 weeks. HLSO preserved L(4)CL and total CL to 90% of non-failing levels (vs. 61-75% in control and lard groups), and attenuated 17-22% decreases in state 3 mitochondrial respiration observed in the control and lard groups (P < 0.05). Left ventricular fractional shortening was significantly higher in HLSO vs. control (33 ± 2 vs. 29 ± 2%, P < 0.05), while plasma insulin levels were lower (5.4 ± 1.1 vs. 9.1 ± 2.3 ng/mL; P < 0.05), with no significant effect of lard supplementation. HLSO also increased serum concentrations of several eicosanoid species compared with control and lard diets, but had no effect on plasma glucose or blood pressure. CONCLUSION: Moderate consumption of HLSO preserves CL and mitochondrial function in the failing heart and may be a useful adjuvant therapy for this condition.


Asunto(s)
Cardiolipinas/metabolismo , Insuficiencia Cardíaca/dietoterapia , Ácido Linoleico/uso terapéutico , Mitocondrias/metabolismo , Aceite de Cártamo/uso terapéutico , Animales , Presión Sanguínea/efectos de los fármacos , Corazón/fisiopatología , Insuficiencia Cardíaca/fisiopatología , Ácido Linoleico/farmacología , Masculino , Ratas , Ratas Endogámicas SHR/metabolismo
9.
Mol Hum Reprod ; 18(5): 253-64, 2012 May.
Artículo en Inglés | MEDLINE | ID: mdl-22180326

RESUMEN

Maternal diabetes increases the risk of embryo malformations. Folic acid and safflower oil supplementations have been shown to reduce embryo malformations in experimental models of diabetes. In this study we here tested whether folic acid and safflower oil supplementations interact to prevent embryo malformations in diabetic rats, and analyzed whether they act through the regulation of matrix metalloproteinases (MMPs), their endogenous inhibitors (TIMPs), and nitric oxide (NO) and reactive oxygen species production. Diabetes was induced by streptozotocin administration prior to mating. From Day 0.5 of pregnancy, rats did or did not receive folic acid (15 mg/kg) and/or a 6% safflower oil-supplemented diet. Embryos and decidua were explanted on Day 10.5 of gestation for further analysis of embryo resorptions and malformations, MMP-2 and MMP-9 activities, TIMP-1 and TIMP-2 levels, NO production and lipid peroxidation. Maternal diabetes induced resorptions and malformations that were prevented by folic acid and safflower oil supplementation. MMP-2 and MMP-9 activities were increased in embryos and decidua from diabetic rats and decreased with safflower oil and folic acid supplementations. In diabetic animals, the embryonic and decidual TIMPs were increased mainly with safflower oil supplementation in decidua and with folic acid in embryos. NO overproduction was decreased in decidua from diabetic rats treated with folic acid alone and in combination with safflower oil. These treatments also prevented increases in embryonic and decidual lipid peroxidation. In conclusion, folic acid and safflower oil supplementations interact and protect the embryos from diabetes-induced damage through several pathways related to a decrease in pro-inflammatory mediators.


Asunto(s)
Diabetes Mellitus Experimental/complicaciones , Suplementos Dietéticos , Ácido Fólico/uso terapéutico , Embarazo en Diabéticas , Efectos Tardíos de la Exposición Prenatal/tratamiento farmacológico , Sustancias Protectoras/uso terapéutico , Aceite de Cártamo/uso terapéutico , Animales , Anomalías Congénitas/etiología , Anomalías Congénitas/prevención & control , Embrión de Mamíferos/efectos de los fármacos , Embrión de Mamíferos/metabolismo , Desarrollo Embrionario/efectos de los fármacos , Femenino , Reabsorción del Feto/prevención & control , Masculino , Metaloproteinasa 2 de la Matriz/metabolismo , Metaloproteinasa 9 de la Matriz/metabolismo , Óxido Nítrico/metabolismo , Embarazo , Resultado del Embarazo , Ratas , Ratas Wistar , Especies Reactivas de Oxígeno/metabolismo
10.
Placenta ; 33(1): 8-16, 2012 Jan.
Artículo en Inglés | MEDLINE | ID: mdl-22098918

RESUMEN

OBJECTIVES: Matrix metalloproteinases (MMPs) are proteolytic enzymes involved in placental development and function, although related to the pro-inflammatory environment when produced in excess. Previous studies have identified MMP-2 and MMP-9 overactivities in the placenta from diabetic rats. In this study, we aimed to determine whether diets supplemented with olive and safflower oil, enriched in natural PPAR ligands, are able to regulate MMP-2 and MMP-9 activities in the placenta and serum from diabetic rats. STUDY DESIGN: Diabetes was induced in rat neonates by streptozotocin administration (90mg/kg s.c.). Control and diabetic rats were fed with 6% olive oil- or 6% safflower oil-supplemented diets from days 0.5-13.5 of gestation. MAIN OUTCOME MEASURES: On day 13.5 of gestation, placentas and sera were isolated for further determination of matrix metalloproteinases (MMPs) 2 and 9 activities by zymography. Placental MMP-2 and MMP-9 protein concentration and immunolocalization were also determined. RESULTS: Sera from diabetic pregnant animals showed MMP-2 and MMP-9 overactivities when compared to controls. Serum MMP-9 activity was significantly decreased when the diabetic animals received the olive and safflower oil dietary treatments. Placentas from diabetic rats showed increased MMP-2 and MMP-9 activities and protein concentrations, and both were decreased when diabetic rats received the olive and safflower dietary treatments. CONCLUSIONS: This study demonstrates that both olive and safflower oil-supplemented diets were able to prevent MMPs overactivities in the placenta from diabetic rats, and that these beneficial effects are reflected in rat sera.


Asunto(s)
Antiinflamatorios no Esteroideos/uso terapéutico , Metaloproteinasa 2 de la Matriz/metabolismo , Metaloproteinasa 9 de la Matriz/metabolismo , Placenta/metabolismo , Aceites de Plantas/uso terapéutico , Embarazo en Diabéticas/dietoterapia , Aceite de Cártamo/uso terapéutico , Animales , Biomarcadores/sangre , Precursores Enzimáticos/metabolismo , Femenino , Ligandos , Metaloproteinasa 2 de la Matriz/sangre , Metaloproteinasa 9 de la Matriz/sangre , Aceite de Oliva , Receptores Activados del Proliferador del Peroxisoma/agonistas , Placenta/inmunología , Placenta/patología , Embarazo , Proteínas Gestacionales/sangre , Proteínas Gestacionales/metabolismo , Embarazo en Diabéticas/inmunología , Embarazo en Diabéticas/metabolismo , Embarazo en Diabéticas/patología , Transporte de Proteínas , Distribución Aleatoria , Ratas , Ratas Wistar , Estreptozocina
11.
Lipids Health Dis ; 10: 186, 2011 Oct 21.
Artículo en Inglés | MEDLINE | ID: mdl-22018327

RESUMEN

BACKGROUND: The plasma lipoprotein response of F1B Golden-Syrian hamsters fed diets high in very long chain (VLC) n-3 polyunsaturated fatty acids (PUFA) is paradoxical to that observed in humans. This anomaly is attributed, in part, to low lipoprotein lipase activity and is dependent on cholesterol status. To further elucidate the mechanism(s) for these responses, hamsters were fed diets containing supplemental fish oil (VLC n-3 PUFA) or safflower oil (n-6 PUFA) (both 10% [w/w]) and either cholesterol-supplemented (0.1% cholesterol [w/w]) or cholesterol-depleted (0.01% cholesterol [w/w] and 10 days prior to killing fed 0.15% lovastatin+2% cholestyramine [w/w]). RESULTS: Cholesterol-supplemented hamsters fed fish oil, relative to safflower oil, had higher non-high density lipoprotein (HDL) cholesterol and triglyceride concentrations (P < 0.001) which were associated with lower hepatic low density lipoprotein (LDL) receptor, sterol regulatory element binding protein (SREBP)-1c and acyl-CoA: cholesterol acyl transferase-2 (ACAT) mRNA and protein (p < 0.05), and higher hepatic apolipoprotein (apo) B-100 and apo E protein levels. In contrast, cholesterol-depleted hamsters fed fish oil, relative to safflower oil, had lower non-HDL cholesterol and triglyceride concentrations (P < 0.001) which were associated with lower hepatic SREBP-1c (p < 0.05) but not apo B-100, apo E or ACAT-2 mRNA or protein levels. Independent of cholesterol status, fish oil fed hamsters had lower HDL cholesterol concentrations (p < 0.001), which were associated with lower hepatic apoA-I protein levels (p < 0.05). CONCLUSION: These data suggest disturbing cholesterol homeostasis in F1B hamsters alters their response to dietary fatty acids, which is reflected in altered plasma lipoprotein patterns and regulation of genes associated with their metabolism.


Asunto(s)
Colesterol/sangre , Ácidos Grasos Omega-3/uso terapéutico , Ácidos Grasos Omega-6/uso terapéutico , Hipercolesterolemia/dietoterapia , Lipoproteínas/sangre , Acetil-CoA C-Acetiltransferasa/genética , Acetil-CoA C-Acetiltransferasa/metabolismo , Animales , Apolipoproteínas/genética , Apolipoproteínas/metabolismo , Colesterol en la Dieta/efectos adversos , Cricetinae , Aceites de Pescado/uso terapéutico , Regulación de la Expresión Génica , Homeostasis , Hipercolesterolemia/sangre , Hipercolesterolemia/metabolismo , Hígado/metabolismo , Masculino , Mesocricetus , ARN Mensajero/metabolismo , Receptores de LDL/genética , Receptores de LDL/metabolismo , Aceite de Cártamo/uso terapéutico , Proteína 1 de Unión a los Elementos Reguladores de Esteroles/genética , Proteína 1 de Unión a los Elementos Reguladores de Esteroles/metabolismo
12.
Ann Nutr Metab ; 58(4): 282-9, 2011 Oct.
Artículo en Inglés | MEDLINE | ID: mdl-21912105

RESUMEN

AIM: The aim of this study was to investigate the effect of different dietary fats on alterations in endurance, energy metabolism, and plasma levels of interleukin-6 (IL-6) and minerals in mice. METHOD: Male mice (aged 58 weeks) were fed diets containing 6% safflower oil, fish oil, or lard for 12 weeks. Swimming time to exhaustion, energy metabolism, and plasma IL-6 levels were subsequently determined. RESULTS: Mice fed safflower oil exhibited a marked increase in swimming time compared to the baseline level. Mice fed lard exhibited a significant decrease in swimming time, while mice on a fish oil diet exhibited a small decrease in swimming time. The final swimming time of mice fed safflower oil was significantly longer than that of animals fed lard. This improvement in endurance with dietary safflower oil was accompanied by decreased accumulation of lactate and less glycogen depletion during swimming. In the safflower oil group, muscle carnitine palmitoyltransferase activity increased significantly after swimming, while the plasma non-esterified fatty acid concentration decreased significantly. A trend to increased plasma IL-6 levels was observed in sedentary animals on a safflower oil diet compared to those on a lard diet. CONCLUSIONS: These results suggest that dietary safflower oil improves the swimming endurance of aged mice to a greater extent than lard, and that this effect appears to involve glycogen sparing through increased fatty acid utilization.


Asunto(s)
Envejecimiento/metabolismo , Metabolismo Energético , Fatiga/prevención & control , Ácidos Grasos Omega-6/uso terapéutico , Músculo Esquelético/metabolismo , Resistencia Física , Aceite de Cártamo/uso terapéutico , Animales , Carnitina O-Palmitoiltransferasa/metabolismo , Grasas de la Dieta/efectos adversos , Grasas de la Dieta/análisis , Fatiga/sangre , Fatiga/metabolismo , Fatiga/fisiopatología , Ácidos Grasos no Esterificados/sangre , Ácidos Grasos Omega-6/análisis , Aceites de Pescado/efectos adversos , Aceites de Pescado/química , Glucógeno/metabolismo , Ácido Láctico/sangre , Ácido Láctico/metabolismo , Hígado/enzimología , Hígado/metabolismo , Masculino , Ratones , Ratones Endogámicos ICR , Músculo Esquelético/enzimología , Músculo Esquelético/fisiopatología , Distribución Aleatoria , Aceite de Cártamo/química , Natación
13.
Pharmacol Res ; 63(5): 377-82, 2011 May.
Artículo en Inglés | MEDLINE | ID: mdl-21345372

RESUMEN

Fish oil has been used to alleviate pain associated with inflammatory conditions such as rheumatoid arthritis. The anti-inflammatory property of fish oil is attributed to the n-3 fatty acids docosahexaenoic acid and eicosapentaenoic acid. Contrarily, vegetable oils such as safflower oil are rich in n-6 fatty acids which are considered to be mediators of inflammation. This study investigates the effect of n-3 and n-6 fatty acids rich oils as dietary supplements on the thermally induced pain sensitivity in healthy mice. C57Bl/6J mice were fed diet containing regular fish oil, concentrated fish oil formulation (CFO) and safflower oil (SO) for 6 months. Pain sensitivity was measured by Plantar test and was correlated to the expression of acid sensing ion channels (ASICs), transient receptor potential vanilloid 1 (TRPV1) and c-fos in dorsal root ganglion cells. Significant delay in sensitivity to thermal nociception was observed in mice fed CFO compared to mice fed SO (p<0.05). A significant diminution in expression of ion channels such as ASIC1a (64%), ASIC13 (37%) and TRPV1 (56%) coupled with reduced expression of c-fos, a marker of neuronal activation, was observed in the dorsal root ganglion cells of mice fed CFO compared to that fed SO. In conclusion, we describe here the potential of fish oil supplement in reducing sensitivity to thermal nociception in normal mice.


Asunto(s)
Ácidos Grasos Omega-3/uso terapéutico , Ácidos Grasos Omega-6/uso terapéutico , Aceites de Pescado/uso terapéutico , Dolor/dietoterapia , Animales , Femenino , Ganglios Espinales/citología , Inmunoquímica , Ratones , Ratones Endogámicos C57BL , Proteínas Proto-Oncogénicas c-fos/inmunología , Aceite de Cártamo/uso terapéutico , Temperatura
14.
J Bone Miner Metab ; 29(4): 404-13, 2011 Jul.
Artículo en Inglés | MEDLINE | ID: mdl-21069546

RESUMEN

Both soy isoflavone and n-3 polyunsaturated fatty acids are known to reduce the levels of bone-resorbing cytokines; however, the synergistic effects of these food ingredients have not been examined yet. This study was performed to elucidate the effect of concomitant intake of soy isoflavone and fish oil on bone mass in ovariectomized mice. Eight-week-old ddY female mice were subjected to ovariectomy (OVX) or sham surgery, and then fed an AIN-93G with safflower oil (So) as a control lipid source, isoflavone-supplemented safflower oil (So + I), fish oil instead of safflower oil (Fo) or isoflavone-supplemented fish oil (Fo + I) for 4 weeks. Femoral bone mineral density was significantly decreased by OVX; however, this decrease was inhibited by the intake of isoflavone and/or fish oil. Histomorphometric analyses showed that bone volume and trabecular thickness in the distal femoral trabecular bone were significantly lower in the So group than in the sham group, but those were restored in the Fo + I groups. The number of osteoclasts was significantly decreased by isoflavone intake. The increased rate of bone resorption after OVX was inhibited by isoflavone and/or fish oil. The serum concentration of tumor necrosis factor alpha was increased after OVX, but was significantly lower with the combination of isoflavone with fish oil than isoflavone or fish oil alone. The results of this study indicated that the intakes of soy isoflavone and/or fish oil might have ameliorating effects on bone loss due to OVX. Further, the concomitant intake of soy isoflavone and fish oil at a low dose showed better effects on cytokines related with bone resorption.


Asunto(s)
Resorción Ósea/tratamiento farmacológico , Aceites de Pescado/uso terapéutico , Glycine max/química , Isoflavonas/uso terapéutico , Ovariectomía , Animales , Biomarcadores/sangre , Peso Corporal/efectos de los fármacos , Densidad Ósea/efectos de los fármacos , Resorción Ósea/patología , Resorción Ósea/fisiopatología , Calcio/metabolismo , Dieta , Quimioterapia Combinada , Conducta Alimentaria/efectos de los fármacos , Femenino , Fémur/efectos de los fármacos , Fémur/patología , Fémur/fisiopatología , Aceites de Pescado/farmacología , Isoflavonas/sangre , Isoflavonas/farmacología , Ratones , Ratones Endogámicos C57BL , Tamaño de los Órganos/efectos de los fármacos , Aceite de Cártamo/uso terapéutico , Útero/efectos de los fármacos , Útero/patología
15.
Vasc Health Risk Manag ; 6: 1007-14, 2010 Nov 03.
Artículo en Inglés | MEDLINE | ID: mdl-21127697

RESUMEN

Safflower seed extract (SSE) contains characteristic polyphenols and serotonin derivatives (N-( p-coumaroyl) serotonin and N-feruloylserotonin), which are reported to inhibit oxidation of low-density lipoprotein (LDL), formation of atherosclerotic plaques, and improve arterial stiffness as assessed by pulse wave analysis in animal models. The effects of long-term supplementation with SSE on arterial stiffness in human subjects were evaluated. This doubleblind, placebo-controlled study was conducted in 77 males (35-65 years) and 15 postmenopausal females (55-65 years) with high-normal blood pressure or mild hypertension who were not undergoing treatment. Subjects received SSE (70 mg/day as serotonin derivatives) or placebo for 12 weeks, and pulse wave measurements, ie, second derivative of photoplethysmogram (SDPTG), augmentation index, and brachial-ankle pulse wave velocity (baPWV) were conducted at baseline, and at weeks 4, 8, and 12. Vascular age estimated by SDPTG aging index improved in the SSE-supplemented group when compared with the placebo group at four (P = 0.0368) and 12 weeks (P = 0.0927). The trend of augmentation index reduction (P = 0.072 versus baseline) was observed in the SSE-supplemented group, but reduction of baPWV by SSE supplementation was not observed. The SSE-supplemented group also showed a trend towards a lower malondialdehyde-modified-LDL autoantibody titer at 12 weeks from baseline. These results suggest long-term ingestion of SSE in humans could help to improve arterial stiffness.


Asunto(s)
Arterias/efectos de los fármacos , Carthamus tinctorius/química , Extractos Vegetales/uso terapéutico , Placa Aterosclerótica/prevención & control , Semillas/química , Adulto , Anciano , Tobillo/irrigación sanguínea , Arterias/fisiopatología , Presión Sanguínea/efectos de los fármacos , Método Doble Ciego , Femenino , Humanos , Hipertensión , Lipoproteínas LDL/sangre , Lipoproteínas LDL/efectos de los fármacos , Masculino , Persona de Mediana Edad , Placebos , Extractos Vegetales/farmacología , Posmenopausia , Flujo Pulsátil/efectos de los fármacos , Aceite de Cártamo/farmacología , Aceite de Cártamo/uso terapéutico , Resultado del Tratamiento
16.
Nutr Clin Pract ; 24(5): 616-25, 2009.
Artículo en Inglés | MEDLINE | ID: mdl-19841249

RESUMEN

Intravenous lipid emulsions (IVLE) are an important source of energy and essential fatty acids and their incorporation into pediatric and adult parenteral nutrition (PN) regimens has revolutionized nutrition therapy. However, their clinical use has not been without risk, and will continue to remain so because of the intravenous route of administration. Pharmaceutical and microbiological concerns are centered around the methods of compounding all-in-one (AIO) admixtures, but these can be largely minimized with today's technologies and advanced understanding of aseptic principles. Modern lipid products, based on olive, coconut, and/or fish oils, have demonstrable formulation and clinical benefits over traditional soybean and safflower IVLE and, when combined in the new multi-chamber bags, can also offer improvements in stability and safety. This review outlines the rationale for different lipid formulations in PN admixtures, reviews the factors influencing stability and efficacy of lipid-based AIO regimens and evaluates some technologies for minimizing peroxidation and maximizing stability of AIO admixtures.


Asunto(s)
Emulsiones Grasas Intravenosas/uso terapéutico , Nutrición Parenteral/métodos , Adulto , Niño , Aceite de Coco , Emulsiones Grasas Intravenosas/administración & dosificación , Emulsiones Grasas Intravenosas/efectos adversos , Aceites de Pescado/administración & dosificación , Aceites de Pescado/efectos adversos , Aceites de Pescado/uso terapéutico , Humanos , Recién Nacido , Peroxidación de Lípido , Aceite de Oliva , Nutrición Parenteral/efectos adversos , Aceites de Plantas/administración & dosificación , Aceites de Plantas/efectos adversos , Aceites de Plantas/uso terapéutico , Aceite de Cártamo/administración & dosificación , Aceite de Cártamo/efectos adversos , Aceite de Cártamo/uso terapéutico , Aceite de Soja/administración & dosificación , Aceite de Soja/efectos adversos , Aceite de Soja/uso terapéutico
17.
Am J Clin Nutr ; 90(3): 468-76, 2009 Sep.
Artículo en Inglés | MEDLINE | ID: mdl-19535429

RESUMEN

BACKGROUND: Weight loss may improve glucose control in persons with type 2 diabetes. The effects of fat quality, as opposed to quantity, on weight loss are not well understood. OBJECTIVE: We compared the effects of 2 dietary oils, conjugated linoleic acid (CLA) and safflower oil (SAF), on body weight and composition in obese postmenopausal women with type 2 diabetes. DESIGN: This was a 36-wk randomized, double-masked, crossover study. Fifty-five obese postmenopausal women with type 2 diabetes received SAF or CLA (8 g oil/d) during two 16-wk diet periods separated by a 4-wk washout period. Subjects met monthly with the study coordinator to receive new supplements and for assessment of energy balance, biochemical endpoints, or anthropometric variables. RESULTS: Thirty-five women completed the 36-wk intervention. Supplementation with CLA reduced body mass index (BMI) (P = 0.0022) and total adipose mass (P = 0.0187) without altering lean mass. The effect of CLA in lowering BMI was detected during the last 8 wk of each 16-wk diet period. In contrast, SAF had no effect on BMI or total adipose mass but reduced trunk adipose mass (P = 0.0422) and increased lean mass (P = 0.0432). SAF also significantly lowered fasting glucose (P = 0.0343) and increased adiponectin (P = 0.0051). No differences were observed in dietary energy intake, total fat intake, and fat quality in either diet period for either intervention. CONCLUSIONS: Supplementation with CLA and SAF exerted different effects on BMI, total and trunk adipose mass, and lean tissue mass in obese postmenopausal women with type 2 diabetes. Supplementation with these dietary oils may be beneficial for weight loss, glycemic control, or both.


Asunto(s)
Composición Corporal/efectos de los fármacos , Peso Corporal/efectos de los fármacos , Diabetes Mellitus Tipo 2/fisiopatología , Ácidos Linoleicos Conjugados/uso terapéutico , Obesidad/tratamiento farmacológico , Aceite de Cártamo/uso terapéutico , Adiponectina/sangre , Tejido Adiposo/efectos de los fármacos , Anciano , Glucemia/metabolismo , Índice de Masa Corporal , Estudios Cruzados , Diabetes Mellitus Tipo 2/complicaciones , Diabetes Mellitus Tipo 2/tratamiento farmacológico , Grasas de la Dieta/farmacología , Grasas de la Dieta/uso terapéutico , Suplementos Dietéticos , Femenino , Humanos , Ácidos Linoleicos Conjugados/farmacología , Persona de Mediana Edad , Obesidad/sangre , Obesidad/complicaciones , Posmenopausia , Aceite de Cártamo/farmacología
18.
J Hepatol ; 49(3): 441-50, 2008 Sep.
Artículo en Inglés | MEDLINE | ID: mdl-18620774

RESUMEN

BACKGROUND/AIMS: We examined whether dietary fish oil can prevent acute ethanol (alcohol)-induced fatty liver. METHODS: Mice were fed safflower oil, fish oil, or safflower oil plus a PPAR alpha activator on the day prior to ethanol administration. Oil red O staining, serum analysis, and RT-PCR were used to analyze ethanol-induced fatty liver. RESULTS: In mice fed safflower oil, ethanol increased liver TG 3-fold, with activation of SREBP-1c and ChREBP, which promote de novo lipogenesis, and increases in expression of mRNAs for PPAR gamma and DGATs mRNAs, which promote TG synthesis. When mice were fed fish oil, ethanol-induced fatty liver was reduced by 73%. Fish oil decreased SREBP-1c activity and increased PPAR alpha activity. However, levels of DGAT1, DGAT2, ChREBP, LPK, and PPAR gamma mRNAs were increased in response to ethanol in mice fed fish oil. Prior administration of Wy14643, PPAR alpha activator, did not inhibit ethanol-induced fatty liver, suggesting that PPAR alpha played little role in prevention of ethanol-induced fatty liver by fish oil. CONCLUSIONS: A single dose of ethanol increases the liver TG level via several mechanisms; however, prior ingestion of fish oil effectively prevents ethanol-induced fatty liver, at least in part, by decreasing basal SREBP-1c activity, especially a marked reduction in SCD1.


Asunto(s)
Grasas Insaturadas en la Dieta/uso terapéutico , Etanol/efectos adversos , Hígado Graso/inducido químicamente , Hígado Graso/prevención & control , Aceites de Pescado/uso terapéutico , Animales , Anticolesterolemiantes/farmacología , Glucemia/metabolismo , Grasas Insaturadas en la Dieta/administración & dosificación , Grasas Insaturadas en la Dieta/farmacología , Relación Dosis-Respuesta a Droga , Ácidos Grasos no Esterificados/sangre , Hígado Graso/metabolismo , Aceites de Pescado/administración & dosificación , Aceites de Pescado/farmacología , Masculino , Ratones , Ratones Endogámicos C57BL , PPAR gamma/metabolismo , Pirimidinas/farmacología , Aceite de Cártamo/uso terapéutico , Estearoil-CoA Desaturasa/metabolismo , Proteína 1 de Unión a los Elementos Reguladores de Esteroles/metabolismo , Triglicéridos/metabolismo
19.
Br J Nutr ; 95(2): 230-3, 2006 Feb.
Artículo en Inglés | MEDLINE | ID: mdl-16469136

RESUMEN

The objective of this investigation was to determine the influence of flaxseed oil on responses representative of primary humoral and cell-mediated adaptive immune competence in immunosenescent mice. Male and female C57BL/6J mice, 85 weeks old, were randomized between two complete purified diets differing only in oil source (cold-pressed safflower or flaxseed). After 8 weeks, humoral competence was assessed in six mice per group as the serum haemagglutinin titre to sheep red blood cells (SRBC) and cell-mediated competence was assessed, in an additional six mice per group, as the delayed hypersensitivity response to SRBC. A zero-time control group (88 weeks old) and a young adult positive control group (12 weeks old) were each tested similarly (six per immune response), revealing age-related depression in both antibody and cell-mediated competence at 88 weeks of age. After the 8-week experimental period, the antibody response of the two test groups of geriatric mice remained below the young adult level (P=0.04) and the cell-mediated response of the safflower oil group also continued to exhibit age-related depression (20 % of young adult level, P=0.0002). By contrast, the anti-SRBC delayed hypersensitivity response of the flaxseed group no longer differed from the response of the young adults but exceeded that of the safflower and zero-time control senescent groups (P=0.0002). Depression in primary cell-mediated competence, the most outstanding aspect of immunosenescence, can be addressed by means of a dietary source of 18 : 3n-3 without longer-chain PUFA.


Asunto(s)
Factores de Edad , Formación de Anticuerpos/efectos de los fármacos , Inmunidad Celular/efectos de los fármacos , Inmunocompetencia/efectos de los fármacos , Aceite de Linaza/uso terapéutico , Adaptación Fisiológica/inmunología , Animales , Formación de Anticuerpos/inmunología , Frío , Eritrocitos/inmunología , Ácidos Grasos/análisis , Femenino , Hipersensibilidad Tardía/inmunología , Inmunidad Celular/inmunología , Inmunocompetencia/inmunología , Masculino , Ratones , Ratones Endogámicos C57BL , Distribución Aleatoria , Aceite de Cártamo/inmunología , Aceite de Cártamo/uso terapéutico
20.
Indian Pediatr ; 42(10): 998-1005, 2005 Oct.
Artículo en Inglés | MEDLINE | ID: mdl-16269830

RESUMEN

OBJECTIVE: To study the transcutaneous absorption of traditionally massaged oil in newborns and to specifically compare the effects of (i) essential fatty acid (EFA) rich - safflower oil and (ii) saturated fat rich coconut oil, on fatty acid profiles of massaged babies. DESIGN: A short term randomised controlled study. SETTING: Tertiary care NICU of a large teaching hospital and a research laboratory of a University complex. METHODS: 120 study babies were randomly assigned to three oil groups (i) safflower oil (n = 40) (ii) coconut oil (n = 40) and (iii) no oil controls (n = 40). In each group, babies were selected in three subsets as per their gestational ages viz (a) less than 34 weeks, (b) 34-37 weeks, (c) greater than 37 weeks. 5 mL of the designated oil was massaged four times a day for five days under controlled conditions of temperature and feeding. Pre and post oil massage samples of blood were analysed for triglycerides and fatty acid profiles using gas chromatography. RESULTS: Post oil triglyceride values were significantly raised in both the oil groups and also in controls. However, the quantum of rise was significantly higher in oil groups as compared to controls. Fatty acid profiles (gas chromatography) showed significant rise in EFAs (linolenic acid and arachidonic acid) in safflower oil group and saturated fats in coconut oil group. Changes were more evident in term babies. There were no side effects associated with the massage. CONCLUSIONS: This study shows that topically applied oil can be absorbed in neonates and is probably available for nutritional purposes. The fatty acid constituents of the oil can influence the changes in the fatty acid profiles of the massaged babies.


Asunto(s)
Ácidos Grasos/farmacocinética , Masaje , Aceites de Plantas/farmacocinética , Absorción Cutánea , Ácidos Grasos/administración & dosificación , Ácidos Grasos Esenciales/uso terapéutico , Femenino , Humanos , Fenómenos Fisiológicos Nutricionales del Lactante , Recién Nacido , Masculino , Aceites de Plantas/administración & dosificación , Aceite de Cártamo/uso terapéutico
SELECCIÓN DE REFERENCIAS
DETALLE DE LA BÚSQUEDA
...